Can atorvastatin with metformin change the natural history of prostate cancer as characterized by molecular, metabolomic, imaging and pathological variables? A randomized controlled trial protocol
Authors:
- Matthew J. RobertsMRMatthew J. Roberts
- John W. YaxleyJYJohn W. Yaxley
- Geoffrey D. CoughlinGCGeoffrey D. Coughlin
- Troy R.J. GianduzzoTGTroy R.J. Gianduzzo
- Rachel C. EslerRERachel C. Esler
- Nigel T. DunglisonNDNigel T. Dunglison
- Suzanne K. ChambersSCSuzanne K. Chambers
- Robyn J. MedcraftRMRobyn J. Medcraft
- Clement W.K. ChowCCClement W.K. Chow
- Horst Joachim SchirraHSHorst Joachim Schirra
- Renee S. RichardsRRRenee S. Richards
- Nicholas KienzleNKNicholas Kienzle
Open Access
- 28 June 2016
- journal article
- research article
- Published by Elsevier in Contemporary Clinical Trials
- Vol. 50, 16-20
Abstract
No abstract availableKeywords
This publication has 36 references indexed in Scilit:
- Statin Use at the Time of Initiation of Androgen Deprivation Therapy and Time to Progression in Patients With Hormone-Sensitive Prostate CancerJAMA Oncology, 2015
- Synergism between metformin and statins in modifying the risk of biochemical recurrence following radical prostatectomy in men with diabetesProstate Cancer and Prostatic Diseases, 2014
- Statins: protectors or pretenders in prostate cancer?Trends in Endocrinology & Metabolism, 2014
- Endocrine-related cancers and the role of AMPKMolecular and Cellular Endocrinology, 2013
- How cancer metabolism is tuned for proliferation and vulnerable to disruptionNature, 2012
- Metformin in prostate cancer: two for the price of oneAnnals of Oncology, 2011
- Understanding the Warburg Effect: The Metabolic Requirements of Cell ProliferationScience, 2009
- Association between plasma cholesterol and prostate cancer in the PSA eraInternational Journal of Cancer, 2008
- Insulin, insulin-like growth factors, insulin resistance, and neoplasiaThe American Journal of Clinical Nutrition, 2007
- On the Origin of Cancer CellsScience, 1956